One similarity with our data is that mice treated with TLR4 antagonist, Eritoran, or TLR4−/− mice had reduced lung pathology to infection with influenza virus, which is characterized by the reduction of viral burden and proinflammatory cytokine expression. Here, TLR4 is linked to infection.